Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

Clinical trial NCT05332925 · RECRUITING

Trial details

NCT number: NCT05332925
Sponsor: Jun Zhang, MD, PhD
Status: RECRUITING
Study type: OBSERVATIONAL

Lung Cancer NSCLC NSCLC Stage IV

Start date: 2022-07-21
Primary completion: 2026-01-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.